Tocilizumab for the Treatment of Familial Mediterranean Fever - A Randomized, Doubleblind, Phase II Proof of Concept Study
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Tocilizumab (Primary)
- Indications Familial Mediterranean fever
- Focus Proof of concept; Therapeutic Use
- 17 Nov 2020 Status changed from recruiting to completed.
- 09 May 2018 Planned End Date changed from 30 Apr 2020 to 30 May 2020.
- 09 May 2018 Planned primary completion date changed from 30 Nov 2019 to 30 Dec 2019.